drugset / Trial / NCT01750437
Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized, double-blind, active-controlled, multi-center phase 2 clinical trial to investigate the safety, tolerability and efficacy of YH1885L in patients with non-erosive reflux disease(NERD)
Timeline
- Start
- 2013-01
- Primary completion
- 2013-10
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 20 mg | — |
| Subject | YH1885L | Unknown | 33.3 mg | — |
| Subject | YH1885L | Unknown | 50 mg | — |
| Subject | YH1885L | Unknown | 66.6 mg | — |
| Subject | YH1885L | Unknown | 100 mg | — |